CRM vs. ABBV

Last updated Jun 9, 2026

CRM (Salesforce, Inc.) and ABBV (AbbVie Inc.) are both stocks. CRM operates in Software - Application (Technology), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CRM returned 8.51%/yr vs 18.63%/yr for ABBV. At a 0.23 correlation, their price movements are largely independent.

Performance

CRM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Salesforce, Inc. (CRM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRM achieves a -30.92% return, which is significantly lower than ABBV's -0.77% return. Over the past 10 years, CRM has underperformed ABBV with an annualized return of 8.51%, while ABBV has yielded a comparatively higher 18.63% annualized return.

CRM

• 1D: -1.68%
• 1M: 0.40%
• YTD: -30.92%
• 6M: -29.37%
• 1Y: -33.00%
• 3Y*: -4.89%
• 5Y*: -4.74%
• 10Y*: 8.51%

ABBV

• 1D: -1.83%
• 1M: 10.68%
• YTD: -0.77%
• 6M: 1.62%
• 1Y: 21.34%
• 3Y*: 21.59%
• 5Y*: 18.74%
• 10Y*: 18.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRM vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRM Salesforce, Inc.	-30.92%	-20.25%	27.76%	98.46%	-47.83%	14.20%	36.82%	18.74%	33.98%	49.33%
ABBV AbbVie Inc.	-0.77%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Correlation

The correlation between CRM and ABBV is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.19
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.23

The correlation between CRM and ABBV shifts across timeframes, from -0.09 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRM : $159.00B ABBV : $395.73B
EPS CRM : $8.59 ABBV : $2.05
PE Ratio CRM : 21.25 ABBV : 108.68
PS Ratio CRM : 3.98 ABBV : 6.30
PB Ratio CRM : 4.64 ABBV : 14.39
Total Revenue (TTM) CRM : $42.83B ABBV : $62.82B
Gross Profit (TTM) CRM : $33.25B ABBV : $46.15B
EBITDA (TTM) CRM : $12.32B ABBV : $17.96B

Return for Risk

CRM vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRM

CRM Risk / Return Rank: 8
CRM Sharpe Ratio Rank: 7
CRM Sortino Ratio Rank: 9
CRM Omega Ratio Rank: 10
CRM Calmar Ratio Rank: 9
CRM Martin Ratio Rank: 4

ABBV

ABBV Risk / Return Rank: 66
ABBV Sharpe Ratio Rank: 70
ABBV Sortino Ratio Rank: 64
ABBV Omega Ratio Rank: 62
ABBV Calmar Ratio Rank: 66
ABBV Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRM vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Salesforce, Inc. (CRM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRM	ABBV	Difference
Sharpe ratio: Return per unit of total volatility	-0.88	0.88	-1.76
Sortino ratio: Return per unit of downside risk	-1.17	1.37	-2.54
Omega ratio: Gain probability vs. loss probability	0.86	1.17	-0.31
Calmar ratio: Return relative to maximum drawdown	-0.84	1.24	-2.08
Martin ratio: Return relative to average drawdown	-1.62	2.77	-4.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRM vs. ABBV - Sharpe Ratio Comparison

The current CRM Sharpe Ratio is -0.88, which is lower than the ABBV Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of CRM and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRM	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.88	0.88	-1.76
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.13	0.82	-0.95
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.24	0.73	-0.49
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.74	-0.29

Drawdowns

CRM vs. ABBV - Drawdown Comparison

The maximum CRM drawdown since its inception was -70.50%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for CRM and ABBV.

Drawdown Indicators

	CRM	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-70.50%	-45.09%	-25.41%
Max Drawdown (1Y) Largest decline over 1 year	-39.36%	-17.32%	-22.04%
Max Drawdown (3Y) Largest decline over 3 years	-54.70%	-20.74%	-33.96%
Max Drawdown (5Y) Largest decline over 5 years	-58.62%	-21.92%	-36.70%
Max Drawdown (10Y) Largest decline over 10 years	-58.62%	-45.09%	-13.53%
Current Drawdown Current decline from peak	-49.87%	-6.55%	-43.32%
Average Drawdown Average peak-to-trough decline	-16.12%	-10.72%	-5.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.48%	7.72%	+12.76%

Volatility

CRM vs. ABBV - Volatility Comparison

Salesforce, Inc. (CRM) has a higher volatility of 16.96% compared to AbbVie Inc. (ABBV) at 6.39%. This indicates that CRM's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRM	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.96%	6.39%	+10.57%
Volatility (6M) Calculated over the trailing 6-month period	31.74%	17.89%	+13.85%
Volatility (1Y) Calculated over the trailing 1-year period	37.87%	24.33%	+13.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.02%	22.91%	+14.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.36%	25.74%	+9.62%

Dividends

CRM vs. ABBV - Dividend Comparison

CRM's dividend yield for the trailing twelve months is around 0.92%, less than ABBV's 3.02% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.02%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
CRM Salesforce, Inc.	0.92%	0.63%	0.48%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

CRM vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Salesforce, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CRM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported a gross profit of 8.56B and revenue of 11.13B. Therefore, the gross margin over that period was 76.9%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

CRM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported an operating income of 2.35B and revenue of 11.13B, resulting in an operating margin of 21.1%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

CRM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Salesforce, Inc. reported a net income of 2.11B and revenue of 11.13B, resulting in a net margin of 18.9%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.

Frequently Asked Questions

Can I hold both CRM and ABBV in my portfolio?

CRM and ABBV have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRM or ABBV?

CRM has higher volatility (16.96%) compared to ABBV (6.39%). In terms of maximum drawdown, CRM dropped -70.50% vs ABBV's -45.09%.

Which has better risk-adjusted returns?

ABBV currently has the higher Sharpe Ratio (0.88 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.